Barry N. Kreiswirth

57.2k total citations · 14 hit papers
514 papers, 38.4k citations indexed

About

Barry N. Kreiswirth is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Barry N. Kreiswirth has authored 514 papers receiving a total of 38.4k indexed citations (citations by other indexed papers that have themselves been cited), including 344 papers in Infectious Diseases, 213 papers in Epidemiology and 178 papers in Molecular Medicine. Recurrent topics in Barry N. Kreiswirth's work include Antibiotic Resistance in Bacteria (178 papers), Antimicrobial Resistance in Staphylococcus (170 papers) and Tuberculosis Research and Epidemiology (166 papers). Barry N. Kreiswirth is often cited by papers focused on Antibiotic Resistance in Bacteria (178 papers), Antimicrobial Resistance in Staphylococcus (170 papers) and Tuberculosis Research and Epidemiology (166 papers). Barry N. Kreiswirth collaborates with scholars based in United States, Canada and China. Barry N. Kreiswirth's co-authors include Liang Chen, Barun Mathema, Richard P. Novick, Frank R. DeLeo, James M. Musser, Patrick M. Schlievert, Michaël Otto, John Kornblum, Natalia Kurepina and Henry F. Chambers and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Barry N. Kreiswirth

505 papers receiving 37.3k citations

Hit Papers

Community-associated meticillin... 1983 2026 1997 2011 2010 1983 1993 2006 1997 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Community-associated meticillin-resistant Staphylococcus aureus
    2010 1.2k citations Frank R. DeLeo, Michaël Otto et al. profile →
  2. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage
    1983 1.2k citations Barry N. Kreiswirth et al. profile →
  3. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule.
    1993 849 citations Barry N. Kreiswirth et al. profile →
  4. Combination of Multiplex PCRs for Staphylococcal Cassette Chromosome mec Type Assignment: Rapid Identification System for mec , ccr , and MajorDifferences in Junkyard Regions
    2006 830 citations Barry N. Kreiswirth et al. Antimicrobial Agents and Chemotherapy profile →
  5. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination
    1997 820 citations Barry N. Kreiswirth, James M. Musser et al. Proceedings of the National Academy of Sciences profile →
  6. Evaluation of Protein A Gene Polymorphic Region DNA Sequencing for Typing ofStaphylococcus aureusStrains
    1999 818 citations Bo Shopsin, Barry N. Kreiswirth et al. Journal of Clinical Microbiology profile →
  7. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
    2000 796 citations Barry N. Kreiswirth, Clifton E. Barry et al. profile →
  8. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
    2004 580 citations Barry N. Kreiswirth, Gilla Kaplan et al. profile →
  9. Role of External Bacterial Flora in the Pathogenesis of Acute Postoperative Endophthalmitis
    1991 501 citations Barry N. Kreiswirth et al. profile →
  10. Regulation of exoprotein gene expression in Staphylococcus aureus by agr
    1986 501 citations Barry N. Kreiswirth et al. profile →
  11. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding
    2014 410 citations Liang Chen, Barun Mathema et al. profile →
  12. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
    2016 393 citations Ryan K. Shields, Liang Chen et al. Antimicrobial Agents and Chemotherapy profile →
  13. Metformin as adjunct antituberculosis therapy
    2014 378 citations Natalia Kurepina, Barry N. Kreiswirth et al. profile →
  14. Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
    2017 369 citations Ryan K. Shields, M. Hong Nguyen et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry N. Kreiswirth United States 102 24.9k 14.1k 12.8k 10.0k 6.9k 514 38.4k
Barbara E. Murray United States 79 19.6k 0.8× 9.5k 0.7× 7.6k 0.6× 6.9k 0.7× 9.8k 1.4× 334 35.4k
Fred C. Tenover United States 88 20.9k 0.8× 11.1k 0.8× 9.0k 0.7× 10.9k 1.1× 12.3k 1.8× 345 39.4k
Michael A. Pfaller United States 132 49.6k 2.0× 8.3k 0.6× 37.9k 3.0× 6.6k 0.7× 8.3k 1.2× 836 68.4k
Ronald N. Jones United States 112 25.5k 1.0× 9.2k 0.7× 20.7k 1.6× 22.5k 2.3× 13.0k 1.9× 1.3k 56.9k
Arnold S. Bayer United States 82 16.3k 0.7× 7.5k 0.5× 10.6k 0.8× 2.5k 0.3× 5.9k 0.9× 372 27.7k
Mary Jane Ferraro United States 48 8.3k 0.3× 7.2k 0.5× 6.5k 0.5× 9.8k 1.0× 5.4k 0.8× 124 30.5k
Alex van Belkum Netherlands 81 15.0k 0.6× 9.9k 0.7× 5.8k 0.5× 2.9k 0.3× 6.6k 1.0× 528 28.6k
Vance G. Fowler United States 82 16.2k 0.7× 5.6k 0.4× 14.9k 1.2× 3.0k 0.3× 7.0k 1.0× 400 31.3k
Yehuda Carmeli Israel 79 8.3k 0.3× 5.6k 0.4× 8.8k 0.7× 20.0k 2.0× 7.0k 1.0× 332 34.2k
Henry F. Chambers United States 74 19.0k 0.8× 7.3k 0.5× 6.6k 0.5× 3.3k 0.3× 9.2k 1.3× 257 27.6k

Countries citing papers authored by Barry N. Kreiswirth

Since Specialization
Citations

This map shows the geographic impact of Barry N. Kreiswirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry N. Kreiswirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry N. Kreiswirth more than expected).

Fields of papers citing papers by Barry N. Kreiswirth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry N. Kreiswirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry N. Kreiswirth. The network helps show where Barry N. Kreiswirth may publish in the future.

Co-authorship network of co-authors of Barry N. Kreiswirth

This figure shows the co-authorship network connecting the top 25 collaborators of Barry N. Kreiswirth. A scholar is included among the top collaborators of Barry N. Kreiswirth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry N. Kreiswirth. Barry N. Kreiswirth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narechania, Apurva, Dean Bobo, Rob DeSalle, et al.. (2025). What Do We Gain When Tolerating Loss? The Information Bottleneck Wrings Out Recombination. Molecular Biology and Evolution. 42(3). 1 indexed citations
2.
Mandecki, Włodek, Wenjuan Ye, Amy Q. Wang, et al.. (2024). Identification of an antibiotic from an HTS targeting EF-Tu:tRNA interaction: a prospective topical treatment for MRSA skin infections. Applied and Environmental Microbiology. 91(1). e0204624–e0204624.
3.
Mediavilla, José R., et al.. (2023). Clonal diversity of Staphylococcus aureus isolates in clinical specimens from selected health facilities in Ethiopia. BMC Infectious Diseases. 23(1). 399–399. 4 indexed citations
4.
Park, Steven, Riccardo Russo, Matthew Zimmerman, et al.. (2022). A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens. Antimicrobial Agents and Chemotherapy. 66(9). e0041422–e0041422. 8 indexed citations
5.
Yu, Fangyou, Astrid V. Cienfuegos-Gallet, Ye Jin, et al.. (2021). Molecular Evolution and Adaptation of Livestock-Associated Methicillin-Resistant Staphylococcus aureus (LA-MRSA) Sequence Type 9. mSystems. 6(3). e0049221–e0049221. 38 indexed citations
6.
Daniels, Joshua B., Liang Chen, Dixie F. Mollenkopf, et al.. (2018). Enterobacter cloacae Complex Sequence Type 171 Isolates Expressing KPC-4 Carbapenemase Recovered from Canine Patients in Ohio. Antimicrobial Agents and Chemotherapy. 62(12). 21 indexed citations
7.
Shields, Ryan K., Liang Chen, Shaoji Cheng, et al.. (2016). Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections. Antimicrobial Agents and Chemotherapy. 61(3). 393 indexed citations breakdown →
8.
Narechania, Apurva, Richard H. Baker, Rob DeSalle, et al.. (2016). Clusterflock: a flocking algorithm for isolating congruent phylogenomic datasets. GigaScience. 5(1). 44–44. 9 indexed citations
9.
Chen, Liang, Barun Mathema, Johann Pitout, Frank R. DeLeo, & Barry N. Kreiswirth. (2014). Epidemic Klebsiella pneumoniae ST258 Is a Hybrid Strain. mBio. 5(3). e01355–14. 156 indexed citations
10.
Rosenthal, Marnie, Lisa L. Dever, Calin S. Moucha, et al.. (2011). Molecular Characterization of an Early Invasive Staphylococcus epidermidis Prosthetic Joint Infection. Microbial Drug Resistance. 17(3). 345–350. 9 indexed citations
11.
DeLeo, Frank R., Adam D. Kennedy, Liang Chen, et al.. (2011). Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proceedings of the National Academy of Sciences. 108(44). 18091–18096. 120 indexed citations
12.
Mediavilla, José R., et al.. (2010). Molecular Characterization and Antibiotic Susceptibility of Staphylococcus aureus from a Multidisciplinary Hospital in Romania. Microbial Drug Resistance. 16(4). 263–272. 14 indexed citations
13.
Zhao, Yanan, Steven Park, Barry N. Kreiswirth, et al.. (2009). Rapid Real-Time Nucleic Acid Sequence-Based Amplification-Molecular Beacon Platform To Detect Fungal and Bacterial Bloodstream Infections. Journal of Clinical Microbiology. 47(7). 2067–2078. 65 indexed citations
14.
Hu, Yi, Barun Mathema, Weibing Wang, et al.. (2008). Prevalence of Multidrug-Resistant Pulmonary Tuberculosis in Counties with Different Duration of DOTS Implementation in Rural China. Microbial Drug Resistance. 14(3). 227–232. 14 indexed citations
15.
Kennedy, Adam D., Michaël Otto, Kevin R. Braughton, et al.. (2008). Epidemic community-associated methicillin-resistant Staphylococcus aureus : Recent clonal expansion and diversification. Proceedings of the National Academy of Sciences. 105(4). 1327–1332. 300 indexed citations
16.
Lazzarini, Luiz Claudio Oliveira, Richard C. Huard, Neio Boéchat, et al.. (2007). Discovery of a Novel Mycobacterium tuberculosis Lineage That Is a Major Cause of Tuberculosis in Rio de Janeiro, Brazil. Journal of Clinical Microbiology. 45(12). 3891–3902. 82 indexed citations
17.
Kaplan, Gilla, Frank A. Post, André L. Moreira, et al.. (2003). Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity. Infection and Immunity. 71(12). 7099–7108. 277 indexed citations
18.
Shopsin, Bo & Barry N. Kreiswirth. (2001). Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus. SHILAP Revista de lepidopterología. 3 indexed citations
19.
Fontanarosa, Phil, Pablo Bifani, Bo Shopsin, et al.. (2000). Molecular Epidemiology and Tuberculosis Control—Reply. JAMA. 284(3). 306–306. 1 indexed citations
20.
Haas, David W., et al.. (1998). Nosocomial Transmission of a Drug-Sensitive W-Variant Mycobacterium tuberculosis Strain Among Patients With Acquired Immunodeficiency Syndrome in Tennessee. Infection Control and Hospital Epidemiology. 19(9). 635–639. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara E. Murray Breakdown of academic impact, for papers by Fred C. Tenover Breakdown of academic impact, for papers by Michael A. Pfaller Breakdown of academic impact, for papers by Ronald N. Jones Breakdown of academic impact, for papers by Arnold S. Bayer Breakdown of academic impact, for papers by Mary Jane Ferraro Breakdown of academic impact, for papers by Alex van Belkum Breakdown of academic impact, for papers by Vance G. Fowler Breakdown of academic impact, for papers by Yehuda Carmeli Breakdown of academic impact, for papers by Henry F. Chambers
Rankless by CCL
2026